Ss Innovations International, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SCHEDULE 13G/A: Major Shareholder Dr. Sudhir Srivastava Discloses 60.60% Stake in SS Innovations International
Dr. Sudhir Srivastava and affiliated entities have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 60.60% of SS Innovations International, Inc.'s common stock as of March 31, 2025.
NASDAQ
Frederic H. Moll has filed an amended Schedule 13G, revealing a beneficial ownership of 11.26% in SS Innovations International, Inc. as of March 31, 2025.
NASDAQ
Barry F. Cohen has reported a 5.4% beneficial ownership stake in SS Innovations International, Inc., comprising 9,177,717 shares of common stock as of December 31, 2024.
NASDAQ
SCHEDULE 13G/A: Founder Dr. Sudhir Srivastava Discloses Over 63% Beneficial Ownership in SS Innovations International
Dr. Sudhir Srivastava and affiliated entities have filed an amended Schedule 13G, revealing a significant beneficial ownership stake of 63.1% in SS Innovations International, Inc.'s common stock as of December 31, 2024.
NASDAQ
SCHEDULE 13G/A: Ranjan R. Pai and Manipal Global Health Services Disclose 8.7% Stake in SS Innovations International, Inc.
An amended Schedule 13G filing reveals that Ranjan R. Pai and Manipal Global Health Services collectively hold an 8.7% beneficial ownership stake in SS Innovations International, Inc. as of December 31, 2024.
NASDAQ
SCHEDULE 13G/A: Frederic H. Moll Discloses 10.6% Beneficial Ownership in SS Innovations International, Inc.
Frederic H. Moll has filed an amended Schedule 13G, reporting a beneficial ownership of 10.6% in SS Innovations International, Inc. as of December 31, 2024.